Phibro Animal Health Corporation (NASDAQ:PAHC) Q1 2025 Earnings Conference Call November 7, 2024 9:00 AM ET
Company Participants
Glenn David - Chief Financial Officer
Jack Bendheim - Chairman-Board of Directors, President & Chief Executive Officer
Daniel Bendheim - Director & Executive Vice President-Corporate Strategy
Larry Miller - Chief Operating Officer
Conference Call Participants
Ekaterina Knyazkova - JPMorgan
Michael Ryskin - Bank of America
Navann Ty - BNP Paribas
Operator
Hello, and thank you for standing by. My name is Regina and I will be your conference operator today. At this time, I would like to welcome everyone to the Phibro Animal Health Corporation First Quarter 2025 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]
I would now like to turn the conference over to Glenn David, Chief Financial Officer. Please go ahead.
Glenn David
Thank you, Regina. Good morning and welcome to the Phibro Animal Health Corporation earnings call for our first quarter ended September 30, 2024. My name is Glenn David, and I'm the Chief Financial Officer of Phibro Animal Health Corporation.
I am joined today on today's call by Jack Bendheim, Phibro's Chairman President and Chief Executive Officer; Donny Bendheim, Director and Executive Vice President of Corporate Strategy; and Larry Miller, Chief Operating Officer.
Today, we will cover our financial performance for our first quarter and provide updated financial guidance for our fiscal year ending June 30, 2025. At the conclusion of our remarks, we will open the lines for your questions.
I would like to remind you that we are providing a simultaneous webcast of this call on our website pahc.com. Also on the Investors section of our website, you will find copies of the earnings press release and quarterly Form 10-Q as well as the transcript and slides discussed and presented on this call.
Our remarks today will include forward-looking statements and actual results could differ materially from those projections. For a list and description of certain factors that could cause results to differ, I refer you to the forward-looking statements section in our earnings press release.
Our remarks include references to certain financial measures which were not prepared in accordance with generally accepted accounting principles or US GAAP. I refer you to the non-GAAP financial information section in our earnings press release for a discussion of these measures. Reconciliations of these non-GAAP financial measures to the most directly comparable US GAAP measures are included in the financial tables that accompany the earnings press release.